Summary
In asynchronously dividing mouse fibroblasts (L-cells) the antibiotic Bleomycin exerts a cytostatic effect by selectively inhibiting DNA-synthesis. Our experiments show scissions in DNA of double and single strands in vivo, leading to small, partly acid soluble DNA pieces. Only after fragmentation of DNA the cells accumulate in G2-phase of the cell cycle. Simultaneously, alterations in the nuclear structure occur. First, the electron-density of eu- and heterochromatic regions decreases, resulting in an over-all loss of chromatin mass. Later, also nucleolar structures are transformed into “nucleolar caps”. Apparently, the fragmentation of DNA leads to a destabilization and denaturation of DNA and consequently to conformational changes of chromatin structure.
Zusammenfassung
An asynchron wachsenden Mäusefibroblasten (L-Zellen) wurden die Effekte von Bleomycin auf die DNS, die phasenspezifische antimitotische Wirkung im Zellcyclus sowie die ultrastrukturellen Veränderungen am Zellkern untersucht.
Unsere Experimente zeigen das Auftreten von Einzel- und Doppelstrangbrüchen der DNS bei Bleomycin behandelten Zellen in vitro. Die celluläre DNS wird dadurch in kleine, teils säurelösliche Fragmente zerlegt. Die behandelten Zellen werden phasenspezifisch in der G2-Phase des Zellcyclus arretiert. Dieser Arrest ist erstnach Fragmentierung der DNS wirksam. Gleichzeitig verändert sich die Zellkernstruktur. In einem ersten Stadium vermindert sich die Elektronendichte sowohl in eu- wie heterochromatischen Bezirken. Die Gesamtmasse des Chromatins nimmt ab. Später beobachtet man eine Segregation der nucleolären Bestandteile zu “nucleolar caps”.
Offenbar führt die Fragmentierung der DNS unter Bleomycin zu einer Destabilisierung und Denaturierung der DNS mit nachfolgender Konformationsänderung der komplexen Chromatinstrukturen.
Similar content being viewed by others
Literatur
Omoto, S., Takita, T., Maeda, K., Umezawa, H., Umezawa, S.: The chemistry of Bleomycin. VIII. The structure of the sugar moiety of Bleomycin A2. J. Antibiot. (Tokyo)25, 752–754 (1972)
Takita, T., Muraoka, Y., Yoshioka, T., Fujii, A., Maeda, K., Umezawa, H.: The chemistry of Bleomycin. IX. The structures of Bleomycin and Phleomycin. J. Antibiot. (Tokyo)25, 755–758 (1972)
Umezawa, H.: Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrobial agents. Chemother.1965, 1079–1085
Umezawa, H., Ishizuka, M., Maeda, K., Takeuchi, T.: Studies on Bleomycin. Cancer20, 891–895 (1967)
Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: Mechanism of action of Bleomycin. Studies with the growing culture of bacterial and tumor cells. J. Antibiot. (Tokyo) A21, 379–386 (1968)
Takeuchi, M., Yamamoto, T.: Effect of Bleomycin on mouse transplantable tumors. J. Antibiot. (Tokyo)21, 631–637 (1968)
Terasima, T., Umezawa, H.: Lethal effects of Bleomycin on cultured mammalian cells. J. Antibiot. (Tokyo) A23, 300–304 (1970)
Ichikawa, T.: Bleomycin a new antitumor antibiotic as a specific agent against the squamous cell carcinoma. J. Jap. med. Ass.61, 487–497 (1969)
Katsuyki, T., Sagawa, Y., Arakawa, T.: Therapeutic effect of Bleomycin for skin tumors. Gann61, 207–218 (1970)
Kimura, K., Sakai, Y., Chihiro, K., Kashikawa, H., Kitahara, T., Inaki, J., Sakano, T., Fujita, H., Jizuka, N., Mikuni, M.: Chemotherapy of malignant lymphoma with special reference to effects of Bleomycin. Jap. J. clin. exp. Med.27, 1593–1601 (1969)
Kimura, I.: Studies on the combined chemotherapy of malignant tumors based on the administration of fibroblast-inhibiting agents. Chemotherapy17, 993–996 (1969)
Oka, S., Sato, K., Nakai, Y., Kurita, K., Hashimoto, K., Oshibe, M.: Sci. Rep. Res. Inst. Tohoku Univ. (Med.)16, 30–36 (1969)
Kimura, I., Onoshi, T., Kunimasa, I., Takano, J.: Treatment of malignant lymphomas with Bleomycin. Cancer29, 58–60 (1972)
Terasima, T., Yasukawa, M., Umezawa, H.: Breaks and rejoining of DNA in cultured mammalian cells treated with Bleomycin. Gann61, 513–516 (1970)
Suzuki, H., Nagai, K., Akutsu, E., Yamaki, H., Tanaka, N., Umezawa, H.: On the mechanism of action of Bleomycin: Strand scission of DNA caused by Bleomycin and its binding to DNA in vitro. Biochim. biophys. Acta (Amst.)228, 331–343 (1971)
Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: On the mechanism of action of Bleomycin: Scission of DNA strands in vitro and in vivo. J. Antibiot. (Tokyo)22, 446–448 (1969)
Haidle, C. W.: Fragmentation of deoxyribonucleic acid by Bleomycin. Molec. Pharmacol.7, 645–652 (1971)
Shirikawa, I., Azegami, M., Ishii, S., Umezawa, H.: Reaction of Bleomycin with DNA: Strand scission of DNA in the absence of sulfhydryl or peroxide compounds. J. Antibiot. (Tokyo)24, 761–766 (1971)
Nagai, K., Yamaki, H., Suzuki, H., Tanaka, N., Umezawa, H.: The combined effects of Bleomycin and sulfhydryl compounds on the thermal denaturation of DNA. Biochim. biophys. Acta (Amst.)179, 165–171 (1969)
Nagai, K., Suzuki, H., Tanaka, N., Umezawa, H.: Decrease of melting temperature and single strand scission of DNA by Bleomycin in the presence of 2-mercaptoethanol. J. Antibiot. (Tokyo) A22, 569–573 (1969)
Müller, W. E. G., Yamazaki, Z.-I., Breter, H.-J., Zahn, R. K.: Action of Bleomycin on DNA and RNA. Europ. J. Biochem.3, 518–525 (1972)
Haidle, C. W., Weiss, K. K., Kuo, M. T.: Release of free bases from deoxyribonucleic acid after reaction with bleomycin. Molec. Pharmacol.8, 531–537 (1972)
Yamazaki, Z., Müller, W. E. G., Zahn, R. K.: Action of Bleomycin on programmed synthesis. Influence on enzymatic DNA, RNA and protein synthesis. Biochim. biophys. Acta (Amst.)308, 412–421 (1973)
Mittermayer, C., Kaden, P., Sandritter, W.: Untersuchungen an teilungssynchronen L-Zellen. I. Optimale Wachstumsbedingungen und Charakterisierung des synchronen Zellsystems. Histochemie12, 67–74 (1968)
Böhm, N., Sandritter, W.: Feulgen hydrolysis of normal and tissue mouse ascites tumor cells. J. Cell Biol.28, 1–7 (1966)
Mollenhauer, H. H.: Plastic embedding mixtures for use in electron-microscopy. Stain Technol.39, 111–114 (1964)
Terasima, T., Tsuboi, A.: Mammalian cell DNA isolated with minimal shearing. A sensitive system for detection stand breaks by radiation. Biochim. biophys. Acta (Amst.)174, 309–314 (1969)
Cohen, A. M., Philips, F. S., Sternberg, S. S.: Studies on the cytotoxicity of Bleomycin in the small intestine of the mouse. Cancer Res.32, 1293–1297 (1972)
Barranco, S. C., Humphrey, R. M.: The effects of Bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res.31, 1218–1223 (1971)
Barranco, S. C., Novak, J. K., Humphrey, R. M.: Response of mammalian cells following treatment with Bleomycin and 1,3-bis(2-chlorethyl)-1-nitrosourea during plateau phase. Cancer Res.33, 691–694 (1973)
Barranco, S. C., Humphrey, R. M.: The effect of 1,3-bis(chloroethyl)-1-nitrosourea on survival and cell progression in Chinese hamster cells. Cancer Res.31, 191–195 (1971)
Bremerskov, V.: Effects of arabinofuranosylcytosine on the DNA synthesis of mammalian cells treated with bleomycin. Europ. J. Cancer9, 25–29 (1973)
Yamaki, H., Suzuki, H., Nagai, K., Tanaka, N., Umezawa, H.: Effects of Bleomycin A2 on deoxyribonuclease, DNA polymerase and ligase reactions. J. Antibiot. (Tokyo), Ser. A24, 178–184 (1971)
Reynolds, R. C., Montgomery, O. B., Hughes, B.: Nucleolar “caps” produced by actinomycin D. Cancer Res.24, 1269–1277 (1964)
Lapis, K., Berhard, W.: The effect of mitomycin-C on the nucleolar fine structure of KB cells in cell culture. Cancer Res.25, 628–645 (1965)
Shiba, S., Terakawi, A., Taguchi, T., Kawamata, J.: Selective inhibition of formation of deoxyribonucleic acid in Escherichia coli by Mitomycin C. Nature (Lond.)183, 1056–1059 (1959)
Bornstein, R. S., Hungerford, D. A., Haller, G., Engstrom, P. F., Yabro, J. W.: Cytogenetic effects of Bleomycin therapy in man. Cancer Res.31, 2004–2007 (1971)
Ogawa, K., Onoe, T.: Nuclear changes produced by Bleomycin in the 3-methyl-cholanthrene-induced mouse epidermal carcinoma cells. Gann60, 503–507 (1969)
Hagedorn, M., Petres, J., Mittermayer, C.: Bleomycin: Tumorzellveränderungen und Gefäßwirkungen beim Patienten. Arch. Derm. Forsch. (im Druck)
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. K. W. Kalkoff zum 65. Geburtstag gewidmet.
Mit Unterstützung des Sonderforschungsbereiches 46 (MOLGRUDENT) der Deutschen Forschungsgemeinschaft.
Wir danken den Herren Peter Kaden und Alfred Rombach für ausgezeichnete technische Mitarbeit.
Rights and permissions
About this article
Cite this article
Mittermayer, C., Osieka, R. & Madreiter, H. Bleomycin: Wirkung auf DNS und zellkernstrukturen in mäusefibroblasten. Arch. Derm. Res. 249, 401–410 (1974). https://doi.org/10.1007/BF00557901
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00557901